-
Je něco špatně v tomto záznamu ?
Mitigation of Exercise Oscillatory Ventilation Score by Cardiac Resynchronization Therapy
I. Cundrle, BD. Johnson, RF. Rea, CG. Scott, VK. Somers, LJ. Olson
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- MeSH
- funkce levé komory srdeční MeSH
- lidé MeSH
- srdeční resynchronizační terapie * MeSH
- srdeční selhání * terapie MeSH
- tepový objem MeSH
- zátěžový test MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Exercise oscillatory ventilation (EOV) is a consequence of ventilatory control system instability and is commonly observed in patients with advanced heart failure (HF); it is associated with adverse prognosis. The goal of this study was to evaluate the effects of cardiac resynchronization therapy (CRT) on oscillatory ventilation as quantified by a proposed EOV score. METHODS AND RESULTS: Consecutive patients with HF (N = 35) who underwent clinically indicated CRT, cardiopulmonary exercise testing and carbon dioxide (CO2) chemosensitivity by rebreathe before and 4-6 months after CRT were included in this post hoc analysis. With CRT, EOV scores improved in 22 patients (63%). In these patients, left ventricular ejection fraction, left atrial volume, brain natriuretic peptide concentration, and CO2 chemosensitivity significantly improved after CRT (P < 0.05). Furthermore, minute ventilation per unit CO2 production significantly decreased, and end-tidal CO2 increased at rest and at peak exercise post-CRT. Multiple regression analysis showed only the change of CO2 chemosensitivity to be significantly associated with the improvement of the EOV score (b = 0.64; F = 11.3; P = 0.004). In the group without EOV score improvement (n = 13), though left ventricular ejection fraction significantly increased with CRT (P = 0.015), no significant changes in ventilation or gas exchange were observed. CONCLUSION: The EOV score was mitigated by CRT and was associated with decreased CO2 chemosensitivity.
Department of Anesthesiology and Intensive Care St Anne's University Hospital Brno Czech Republic
Department of Biomedical Statistics and Informatics Mayo Clinic Rochester MN USA
Department of Cardiovascular Diseases Mayo Clinic Rochester MN USA
Faculty of Medicine Masaryk University Brno Czech Republic
International Clinical Research Center St Anne's University Hospital Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21026525
- 003
- CZ-PrNML
- 005
- 20211026132829.0
- 007
- ta
- 008
- 211013s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.cardfail.2020.03.006 $2 doi
- 035 __
- $a (PubMed)32205188
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Cundrle, Ivan $u Department of Anesthesiology and Intensive Care, St. Anne's University Hospital, Brno, Czech Republic; Faculty of Medicine, Masaryk University, Brno, Czech Republic; International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic
- 245 10
- $a Mitigation of Exercise Oscillatory Ventilation Score by Cardiac Resynchronization Therapy / $c I. Cundrle, BD. Johnson, RF. Rea, CG. Scott, VK. Somers, LJ. Olson
- 520 9_
- $a BACKGROUND: Exercise oscillatory ventilation (EOV) is a consequence of ventilatory control system instability and is commonly observed in patients with advanced heart failure (HF); it is associated with adverse prognosis. The goal of this study was to evaluate the effects of cardiac resynchronization therapy (CRT) on oscillatory ventilation as quantified by a proposed EOV score. METHODS AND RESULTS: Consecutive patients with HF (N = 35) who underwent clinically indicated CRT, cardiopulmonary exercise testing and carbon dioxide (CO2) chemosensitivity by rebreathe before and 4-6 months after CRT were included in this post hoc analysis. With CRT, EOV scores improved in 22 patients (63%). In these patients, left ventricular ejection fraction, left atrial volume, brain natriuretic peptide concentration, and CO2 chemosensitivity significantly improved after CRT (P < 0.05). Furthermore, minute ventilation per unit CO2 production significantly decreased, and end-tidal CO2 increased at rest and at peak exercise post-CRT. Multiple regression analysis showed only the change of CO2 chemosensitivity to be significantly associated with the improvement of the EOV score (b = 0.64; F = 11.3; P = 0.004). In the group without EOV score improvement (n = 13), though left ventricular ejection fraction significantly increased with CRT (P = 0.015), no significant changes in ventilation or gas exchange were observed. CONCLUSION: The EOV score was mitigated by CRT and was associated with decreased CO2 chemosensitivity.
- 650 12
- $a srdeční resynchronizační terapie $7 D058406
- 650 _2
- $a zátěžový test $7 D005080
- 650 12
- $a srdeční selhání $x terapie $7 D006333
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a tepový objem $7 D013318
- 650 _2
- $a funkce levé komory srdeční $7 D016277
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Johnson, Bruce D $u Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA
- 700 1_
- $a Rea, Robert F $u Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA
- 700 1_
- $a Scott, Christopher G $u Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA
- 700 1_
- $a Somers, Virend K $u Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA
- 700 1_
- $a Olson, Lyle J $u Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA. Electronic address: Olson.Lyle@mayo.edu
- 773 0_
- $w MED00002565 $t Journal of cardiac failure $x 1532-8414 $g Roč. 26, č. 10 (2020), s. 832-840
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32205188 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026132835 $b ABA008
- 999 __
- $a ok $b bmc $g 1715293 $s 1147032
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 26 $c 10 $d 832-840 $e 20200320 $i 1532-8414 $m Journal of cardiac failure $n J Card Fail $x MED00002565
- LZP __
- $a Pubmed-20211013